Table 4.

Adherence to Get With The Guidelines-Heart Failure Quality Metrics Stratified by Testing for Coronary Artery Disease

	CAD Testing N = 6736	No CAD Testing N = 10,449	Standardized Differences
In-hospital care
DVT prophylaxis	71.7	73.7	3.2
Influenza vaccination	75.5	74.1	3.4
Pneumococcal vaccination	73.2	72.8	0.8
Discharge care
ACEI/ARB	97.1	95.3	9.4
Evidence-based β-blockers	85.4	79.6	7.0
Aldosterone antag	31.5	20.8	24.6
Hydralazine & nitrate	16.4	13.1	9.3
Hypertension control	75.1	72.2	6.5
Lipid lowering medications	51.3	44.0	14.6
Diabetes treatment	53.2	50.1	6.3
Anticoagulation for atrial fib/flutter	82.4	77.8	11.7
CRT placed or prescribed	30.4	22.2	18.6
ICD counseling, placed, or prescribed	24.4	18.6	14.3
Follow-up visit ≤7 days	73.5	76.2	6.2

We considered standardized differences ≥10% as statistically significant

Atrial fib, atrial fibrillation, ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; Aldosterone Antag, aldosterone antagonist; Atrial fib, fibrillation; CAD, coronary artery disease; DVT, deep vein thrombosis; CRT, cardiac resynchronization therapy, ICD, implantable cardioverter-defibrillator